Resource and cost considerations in treating hypoplastic left heart syndrome

Miguel Urencio,1 Chris Greenleaf,1 Jorge D Salazar,2 Ali Dodge-Khatami2 1Division of Cardiothoracic Surgery, 2Children’s Heart Center, University of Mississippi Medical Center, Jackson, MS, USA Abstract: Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1983, wh...

Full description

Bibliographic Details
Main Authors: Urencio M, Greenleaf C, Salazar JD, Dodge-Khatami A
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:Pediatric Health, Medicine and Therapeutics
Subjects:
Online Access:https://www.dovepress.com/resource-and-cost-considerations-in-treating-hypoplastic-left-heart-sy-peer-reviewed-article-PHMT
_version_ 1819043223931191296
author Urencio M
Greenleaf C
Salazar JD
Dodge-Khatami A
author_facet Urencio M
Greenleaf C
Salazar JD
Dodge-Khatami A
author_sort Urencio M
collection DOAJ
description Miguel Urencio,1 Chris Greenleaf,1 Jorge D Salazar,2 Ali Dodge-Khatami2 1Division of Cardiothoracic Surgery, 2Children’s Heart Center, University of Mississippi Medical Center, Jackson, MS, USA Abstract: Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1983, when surgical treatment was first undertaken with the Norwood I operation as the first of 3-staged operations. Since then, operative survival rate of stage I has risen from 53% to over 90% in the current era, not only thanks to technical advances in surgery but also through prenatal diagnosis and imaging, enhanced cardiopulmonary bypass technology, better perioperative intensive care, and closer interstage monitoring. The improvements in patient outcomes achieved through rigorous multidisciplinary teamwork have come at a tremendous cost in manpower and resources, making HLHS still a challenge to all congenital heart programs, established or emerging. We review the various surgical steps to treat HLHS and their current expected outcomes, and put into perspective cost considerations compared to other more “simple” congenital heart defects. Keywords: hypoplastic left heart syndrome, Norwood, congenital heart disease
first_indexed 2024-12-21T09:53:23Z
format Article
id doaj.art-34b592473f41406cba0d194d2f032c62
institution Directory Open Access Journal
issn 1179-9927
language English
last_indexed 2024-12-21T09:53:23Z
publishDate 2016-11-01
publisher Dove Medical Press
record_format Article
series Pediatric Health, Medicine and Therapeutics
spelling doaj.art-34b592473f41406cba0d194d2f032c622022-12-21T19:08:08ZengDove Medical PressPediatric Health, Medicine and Therapeutics1179-99272016-11-01Volume 714915330064Resource and cost considerations in treating hypoplastic left heart syndromeUrencio MGreenleaf CSalazar JDDodge-Khatami AMiguel Urencio,1 Chris Greenleaf,1 Jorge D Salazar,2 Ali Dodge-Khatami2 1Division of Cardiothoracic Surgery, 2Children’s Heart Center, University of Mississippi Medical Center, Jackson, MS, USA Abstract: Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1983, when surgical treatment was first undertaken with the Norwood I operation as the first of 3-staged operations. Since then, operative survival rate of stage I has risen from 53% to over 90% in the current era, not only thanks to technical advances in surgery but also through prenatal diagnosis and imaging, enhanced cardiopulmonary bypass technology, better perioperative intensive care, and closer interstage monitoring. The improvements in patient outcomes achieved through rigorous multidisciplinary teamwork have come at a tremendous cost in manpower and resources, making HLHS still a challenge to all congenital heart programs, established or emerging. We review the various surgical steps to treat HLHS and their current expected outcomes, and put into perspective cost considerations compared to other more “simple” congenital heart defects. Keywords: hypoplastic left heart syndrome, Norwood, congenital heart diseasehttps://www.dovepress.com/resource-and-cost-considerations-in-treating-hypoplastic-left-heart-sy-peer-reviewed-article-PHMTHypoplastic Left Heart SyndromeNorwoodCongenital Heart Disease
spellingShingle Urencio M
Greenleaf C
Salazar JD
Dodge-Khatami A
Resource and cost considerations in treating hypoplastic left heart syndrome
Pediatric Health, Medicine and Therapeutics
Hypoplastic Left Heart Syndrome
Norwood
Congenital Heart Disease
title Resource and cost considerations in treating hypoplastic left heart syndrome
title_full Resource and cost considerations in treating hypoplastic left heart syndrome
title_fullStr Resource and cost considerations in treating hypoplastic left heart syndrome
title_full_unstemmed Resource and cost considerations in treating hypoplastic left heart syndrome
title_short Resource and cost considerations in treating hypoplastic left heart syndrome
title_sort resource and cost considerations in treating hypoplastic left heart syndrome
topic Hypoplastic Left Heart Syndrome
Norwood
Congenital Heart Disease
url https://www.dovepress.com/resource-and-cost-considerations-in-treating-hypoplastic-left-heart-sy-peer-reviewed-article-PHMT
work_keys_str_mv AT urenciom resourceandcostconsiderationsintreatinghypoplasticleftheartsyndrome
AT greenleafc resourceandcostconsiderationsintreatinghypoplasticleftheartsyndrome
AT salazarjd resourceandcostconsiderationsintreatinghypoplasticleftheartsyndrome
AT dodgekhatamia resourceandcostconsiderationsintreatinghypoplasticleftheartsyndrome